Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis).

[1]  P. Raggi,et al.  Calcification in atherosclerosis , 2009, Nature Reviews Cardiology.

[2]  I. Kronzon,et al.  Osteoporosis treatment and progression of aortic stenosis. , 2009, The American journal of cardiology.

[3]  M. Criqui,et al.  Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. , 2008, American journal of epidemiology.

[4]  Michael Motro,et al.  Calcification of the Thoracic Aorta as Detected by Spiral Computed Tomography Among Stable Angina Pectoris Patients: Association With Cardiovascular Events and Death , 2008, Circulation.

[5]  R. Sacco,et al.  Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study. , 2008, JACC. Cardiovascular imaging.

[6]  M. Kwak,et al.  Inhibitory effect of simvastatin on the TNF-α- and angiotensin II-induced monocyte adhesion to endothelial cells is mediated through the suppression of geranylgeranyl isoprenoid-dependent ROS generation , 2008, Archives of pharmacal research.

[7]  S. Boonen,et al.  Zoledronic acid and clinical fractures and mortality after hip fracture. , 2007, The New England journal of medicine.

[8]  V. Fuster,et al.  Insights into degenerative aortic valve disease. , 2007, Journal of the American College of Cardiology.

[9]  S. Cummings,et al.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. , 2007, The New England journal of medicine.

[10]  P. Thomas.  Racial and Ethnic Differences in Osteoporosis , 2007, The Journal of the American Academy of Orthopaedic Surgeons.

[11]  F. Cantatore,et al.  Extra-skeletal effects of bisphosphonates. , 2007, Joint, bone, spine : revue du rhumatisme.

[12]  S. Boonen,et al.  Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture. , 2007, The New England journal of medicine.

[13]  R. Langer,et al.  Mitral and Aortic Annular Calcification Are Highly Associated With Systemic Calcified Atherosclerosis , 2006, Circulation.

[14]  R. Kronmal,et al.  Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. , 2006, Academic radiology.

[15]  K. Eishi,et al.  Effect of Etidronic Acid on Arterial Calcification in Dialysis Patients , 2006, Clinical drug investigation.

[16]  Zahi A Fayad,et al.  Atherothrombosis and high-risk plaque: part I: evolving concepts. , 2005, Journal of the American College of Cardiology.

[17]  Michael McNitt-Gray,et al.  Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility--MESA study. , 2005, Radiology.

[18]  E. Mohler,et al.  Paradoxical Effects of Statins on Aortic Valve Myofibroblasts and Osteoblasts: Implications for End-Stage Valvular Heart Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[19]  K. Berkner.  The vitamin K-dependent carboxylase. , 2000, The Journal of nutrition.

[20]  K. Nitta,et al.  Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  G. Zou,et al.  A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.

[22]  A. Urtti,et al.  Effect of Liposomal and Free Bisphosphonates on the IL-1β, IL-6 and TNFα Secretion from RAW 264 Cells in Vitro , 1995, Pharmaceutical Research.

[23]  P. Pennisi,et al.  Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. , 2004, Osteoporosis International.

[24]  M. Budoff,et al.  Valvular and thoracic aortic calcium as a marker of the extent and severity of angiographic coronary artery disease. , 2003, American heart journal.

[25]  Kiang Liu,et al.  Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events: A 37-Month Follow-Up of 5635 Initially Asymptomatic Low- to Intermediate-Risk Adults , 2003, Circulation.

[26]  S. Gonnelli,et al.  Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate. , 2003, Bone.

[27]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[28]  Mark Helfand,et al.  Screening for Postmenopausal Osteoporosis: A Review of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[29]  I. Fishbein,et al.  Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and Rabbits , 2002, Circulation.

[30]  R. Bonow,et al.  Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve , 2002, Circulation.

[31]  P. Price,et al.  Bisphosphonates Alendronate and Ibandronate Inhibit Artery Calcification at Doses Comparable to Those That Inhibit Bone Resorption , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Emile R. Mohler,et al.  Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.

[33]  Alan Garfinkel,et al.  Role of Lipids in Osteoporosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[34]  S. Adami,et al.  Chronic Intravenous Aminobisphosphonate Therapy Increases High‐Density Lipoprotein Cholesterol and Decreases Low‐Density Lipoprotein Cholesterol , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  P. Croucher,et al.  The pharmacology of bisphosphonates and new insights into their mechanisms of action , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  Bonnie K. Lind,et al.  Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. , 1999, The New England journal of medicine.

[37]  P. Price,et al.  Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[38]  M. Rogers,et al.  Nitrogen‐Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post‐Translational Prenylation of GTP‐Binding Proteins, Including Ras , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  F. Parhami,et al.  Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[40]  A. Urtti,et al.  Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro. , 1995, Pharmaceutical research.

[41]  P. Savage,et al.  Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. , 1992, Journal of clinical epidemiology.

[42]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[43]  J. Suttie.  Vitamin K-dependent carboxylase. , 2001, Annual review of biochemistry.

[44]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.